RIGONTEC
Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options.
RIGONTEC
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Martinsried, Bayern, Germany
Country:
Germany
Total Employee:
11+
Status:
Closed
Contact:
+498920006640
Email Addresses:
[email protected]
Total Funding:
29.25 M EUR
Current Employees Featured
Founder
Investors List
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series A - Rigontec
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series A - Rigontec
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Series A - Rigontec
Wellington Partners
Wellington Partners investment in Series A - Rigontec
NRW.BANK
NRW.BANK investment in Series A - Rigontec
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Rigontec
Forbion Capital Partners
Forbion Capital Partners investment in Series A - Rigontec
Forbion Capital Partners
Forbion Capital Partners investment in Series A - Rigontec
NRW.BANK
NRW.BANK investment in Series A - Rigontec
Wellington Partners
Wellington Partners investment in Series A - Rigontec